Dr. Xinhong He 何新红
Chief Physician, Associate Professor
Department of Interventional Therapy, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Interventional minimally invasive treatments for primary and metastatic lung and liver cancer, including radiofrequency, microwave, and cryoablation. Management of recurrent rectal and cervical cancer, soft tissue sarcoma, and image-guided biopsies of difficult sites.
Dr. He holds a clinical medicine doctorate from Second Military Medical University and trained at Sunnybrook Health Sciences Centre, University of Toronto, in ablation techniques. The physician focuses on solid tumor ablation and soft tissue sarcoma. Dr. He has led three research projects, published 31 papers (11 SCI-indexed), and co-authored five books.
Professional roles
- Member, Youth Committee of Tumor Intervention Professional Committee, China Anti-Cancer Association
- Member, Liver Cancer Expert Committee of Tumor Intervention Professional Committee, China Anti-Cancer Association
- Standing Committee Member and Secretary-General, Solid Tumor Focused Diagnosis and Treatment Professional Committee, Shanghai Anti-Cancer Association
- Member, Tumor Non-vascular Intervention Group, Interventional Medicine Branch, Chinese Medical Association
Name order: in Chinese the family name comes first (He Xinhong). Papers usually list the name as Xinhong He or He X.
Selected publications
32 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- World J Gastroenterol, 2025 (senior author): Radiofrequency ablation with or without capecitabine maintenance therapy for lung oligometastases from colorectal cancer. PubMed 41024768
- Heliyon, 2024 (senior author): OIP5-AS1 enhances the malignant characteristics and resistance to chemotherapy of pancreatic cancer cells by targeting miR-30d-5p/MARCH8. PubMed 39050450
- Cardiovasc Intervent Radiol, 2020 (senior author): Contralateral Dependent Position During Percutaneous CT-Guided Core Needle Biopsy for Small (≤ 20 mm) Lung Lesions Adjacent to the Pericardium: Effect on Procedures and Complications. PubMed 32803284
- Jpn J Radiol, 2020 (senior author): Cardiac motion non-influential in percutaneous computed tomography-guided biopsies of small (≤ 20 mm) lung nodules near pericardium. PubMed 32297063
- Anticancer Drugs, 2018 (senior author): Construction and characterization of regulated cycle inhibiting factors induced upon Tet-On system in human colon cancer cell lines. PubMed 29923895
- Dis Markers, 2018 (senior author): Upregulation of the Long Noncoding RNA SNHG3 Promotes Lung Adenocarcinoma Proliferation. PubMed 30154938
- J Neuroimaging, 2014 (first author): Endovascular treatment of posttraumatic carotid-cavernous fistulas and pseudoaneurysms with covered stents. PubMed 23621764
- World J Gastroenterol, 2013 (first author): Metabonomic studies of pancreatic cancer response to radiotherapy in a mouse xenograft model using magnetic resonance spectroscopy and principal components analysis. PubMed 23864784
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion